YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
MDxHealth now carries a refreshed fair value estimate of US$1.80, down from US$2.20, which marks about an 18% reduction in the central price target used in the latest analyst model. This shift reflects recent commentary that weighs progres…
Image source: The Motley Fool. DATE Thursday, Aug. 13, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Chief Executive Officer - Michael McGarrity Interim Chief Financial Officer - Ron Kalfus Full Conference Call Transcript Operator: Please note th…
MDxHealth S.A. Q2 2026 Earnings Call Summary - Moby Strategic Pivot and Operational Recovery Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap…
(RTTNews) - MDxHealth SA (MDXH), a precision diagnostics company, on Friday announced receipt of an additional notification letter from The Nasdaq Stock Market LLC, reiterating the company's minimum bid price deficiency. The company previo…
mdxhealth Mdxhealth Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Listed Securities Deficiency IRVINE, California – July 24, 2026 (GlobeNewswire) – Mdxhealth SA (NASDAQ: MDXH) (the "Company" or "mdxhealth"), a…
(RTTNews) - MDxHealth SA (MDXH), a urology-focused precision diagnostics company, on Thursday announced receipt of a notification letter on June 30, 2026, from the Listing Qualifications Department of The Nasdaq Stock Market LLC, disclosin…
mdxhealth IRVINE, California – July 2, 2026 (GlobeNewswire) – Mdxhealth SA (NASDAQ: MDXH) (the "Company" or "mdxhealth"), a leader in urology-focused precision diagnostics, today announced that the Company received a notification letter (t…
Key Points Interested in MDxHealth SA? Here are five stocks we like better. MDxHealth is exiting its Resolve UTI business and plans to close its Plano, Texas lab, citing reimbursement uncertainty and a dispute with Medicare administrator N…
On Wednesday, MDxHealth (NASDAQ:MDXH) discussed first-quarter financial results during its earnings call. The full transcript is provided below. This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog…
Gainers Staar Surgical (NASDAQ:STAA) shares rose 15.3% to $33.9 during Wednesday's after-market session. The company's market cap stands at $1.3 billion. As per the press release, Q1 earnings came out today. Precision Optics Corp (NASDAQ:P…
Companies Reporting Before The Bell • Similarweb (NYSE:SMWB) is estimated to report quarterly earnings at $0.01 per share on revenue of $72.97 million. • Dominari Holdings (NASDAQ:DOMH) is projected to report earnings for its first quarter…
Quant rankings for the upcoming earnings calendar show strength concentrated across financials, consumer discretionary, and select industrial names, while weakness is more pronounced in health care and pockets of information technology. A…
Tempus AI (TEM) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.21. This compares to a loss of $0.24 per share a year ago. These figures are adjusted for non-recurring items. This quart…
[Wall street and Broadway road sign in New York City] Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week. MONDA…
[Wall street and Broadway road sign in New York City] Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week. SUNDA…
Company Logo Dublin, March 20, 2026 (GLOBE NEWSWIRE) -- The "Liquid Biopsy Product Market Report: Trends, Forecast and Competitive Analysis to 2031" has been added to ResearchAndMarkets.com's offering. The global liquid biopsy product mark…
Image source: The Motley Fool. DATE Thursday, February 26, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Chief Executive Officer — Michael McGarrity Interim Chief Financial Officer — Ron Kalfus Full Conference Call Transcript Michael McGarrity: T…
Mdxhealth to Present Fourth Quarter and Full Year 2025 Financial Resultsand Corporate Update on February 26 Company to Host Conference Call with Live Q&A, February 26, 2026, at 4:30pm ET / 22:30 CET IRVINE, California – February 12, 2026 (…
mdxhealth MDxHealth Reports Preliminary Fourth Quarter and Full Year 2025 Revenues, Issues 2026 Revenue Guidance, and Amends Earnout Terms with Exact Sciences IRVINE, CA – January 12, 2026 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH) (the…
Mdxhealth and University of Oxford to validate GPS test in largest randomized trial of treatment effectiveness in patients with localized prostate cancer IRVINE, CA – January XX, 2026 (GlobeNewswire) – Mdxhealth SA (NASDAQ: MDXH) (the “Com…
Health care stocks were edging higher premarket Tuesday, with the State Street Health Care Select Se PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
Image source: The Motley Fool. Date Wednesday, Nov. 12, 2025 at 4:30 p.m. ET Call participants Chief Executive Officer — Michael McGarrity Interim Chief Financial Officer — Scott McMahon Need a quote from a Motley Fool analyst? Email pr@fo…
mdxhealth Mdxhealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2025 Q3 revenues increased by 18% to $27.4 million Adjusted EBITDA profitability of $1.0 million for Q3 Acquisition of ExoDx business from…
Mdxhealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2025 Q3 revenues increased by 18% to $27.4 million Adjusted EBITDA profitability of $1.0 million for Q3 Acquisition of ExoDx business from Bio-Techne…
MDxHealth SA (NASDAQ:MDXH) is among the best fundamentally strong penny stocks to buy right now. On September 15, 2025, MDxHealth SA (NASDAQ:MDXH) announced the completion of its acquisition of Bio-Techne Corporation’s ExoDx business, incl…
Mdxhealth Announces Closing of Exosome Diagnostics Acquisition from Bio-Techne IRVINE, CA, and HERSTAL, BELGIUM – September 15, 2025 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH) (the "Company" or "mdxhealth"), a leading precision diagnost…
mdxhealth Mdxhealth Announces Closing of Exosome Diagnostics Acquisition from Bio-Techne IRVINE, CA, and HERSTAL, BELGIUM – September 15, 2025 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH) (the "Company" or "mdxhealth"), a leading precisio…
MDxHealth SA ADR, a $136 million market cap diagnostics company, reported its second-quarter 2025 earnings, revealing a strong revenue performance with a 20% increase to $26.6 million. Despite missing earnings per share (EPS) expectations…
Investing.com - MDxHealth ADR (NASDAQ: MDXH) reported second quarter EPS of $-0.150, $0.03 worse than the analyst estimate of $-0.117. Revenue for the quarter came in at $26.61M versus the consensus estimate of $26.34M. MDxHealth ADR’s sto…
MDxHealth SA (MDXH) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to a loss of $0.31 per share a year ago. These figures are adjusted for non-recurring items. This q…
* Bio-Techne (NASDAQ:TECH [https://seekingalpha.com/symbol/TECH]) on Tuesday announced an agreement where Mdxhealth SA will acquire its Exosome Diagnostics business, including the ExoDx Prostate (EPI [https://seekingalpha.com/symbol/EPI])…
MINNEAPOLIS, Aug. 5, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced an agreement where Mdxhealth SA will acquire its Exosome Diagnostics Inc. business, including the ExoDx Prostate (EPI) test, CLIA-certified cli…
Mdxhealth ReportsPreliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, andAnnounces Acquisition of Exosome DiagnosticsBusiness from Bio-Techne Year-over-yearQ2revenues increased by 20% to $26.6 million Adjusted EBITDA…
IRVINE, CA, and HERSTAL, BELGIUM – July 3, 2025 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH) (the "Company" or "mdxhealth"), a leading precision diagnostics company, today announced the appointment of Michael Holder to its Board of Direct…
Fourth quarter revenue growth of 28% to $24.7 million 2024 revenue growth of 28% to $90.0 million 68% improvement in adjusted EBITDA in fourth quarter Conference call with Q&A today at 4:30 PM EST / 22:30 CET IRVINE, CA, and HERSTAL, BELGI…
Company to Host Conference Call with Live Q&A, February 26, 2025, at 4:30pm ET / 22:30 CET IRVINE, CA, and HERSTAL, BELGIUM – February 12, 2025 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH), a leading precision diagnostics company, today a…